Charité researchers secure two new ERC Consolidator Grants
Pioneering research in the fields of neuroscience and pediatric endocrinology
3 Min
More 
Interview with: Prof. Georg N. Duda and Bianca Lemke, Charité and cooperation partner Dr. Lutz Kloke, Cellbricks
Researchers at the Berlin Institute of Health in the Charité (BIH) have teamed up with colleagues from Cellbricks to develop a 3D printer that can produce a biological wound closure. The development is intended to reach high altitudes and help…
1 Min
More Adrenomed Supervisory Board appoints Dr. Richard Jones as CEO
Hennigsdorf/Berlin (Germany), 15 March, 2022 – Adrenomed AG, the vascular integrity company, today announced the appointment of Dr. Richard Jones as Chief Executive Officer of Adrenomed, effective today. Dr. Jones brings over 25 years of experience…
3 Min
More Planck Institute of Molecular Plant Physiology developed a novel strategy to identify protein-molecules that have regulatory functions in stress reduction
Cinderella of chemical biology
3 Min
More Technische Universität Berlin has developed an algorithm that generates targeted molecules based on their desired properties
Whether in medicine, battery research, or materials science, researchers everywhere are seeking innovative substances. In the process, they can often predict the desired chemical and physical properties in great detail, right down to atomic level.…
2 Min
More Berlin Institute of Health at Charité (BIH) and Cellbricks develop a 3D printer that can produce a biological wound closure
Scientists at the Berlin Institute of Health at Charité (BIH) have teamed up with a company called Cellbricks to develop a 3D printer that can produce a biological wound closure: Using a mix of gelatin and skin cells, the device prints a perfectly…
3 Min
More Researchers from Charité and MDC discover reasons for treatment resistance of multiple myeloma
Multiple myeloma, the most common type of bone marrow cancer in Germany, almost always returns, even after initial treatment success. In the majority of cases, the reasons behind this treatment resistance (e.g., genetic mutations) and the subsequent…
4 Min
More MDC researchers describe alterations in the gut microbiome that play a role in cardiovascular disease development
Changes in the gut microbiome can ultimately lead to cardiovascular disease. Yet some of the alterations appear to normalize in chronic conditions, a team led by ECRC researcher Sofia Forslund reports in Nature Medicine. This finding may have…
4 Min
More Speed Lecture Award 2022
The HealthCapital Cluster Berlin and the Interest Group Biotechnology of the German Association of Research Based Pharmaceutical Companies (vfa bio) will award the most captivating research pitches at this year´s BIONNALE 2022.
Young scientists…
1 Min
More Dr. Lutz Hilbrich, Chief Executive Officer at ProBioGen (and the subsidiary MiGenTra) and Andrea Hauptmann, Chief Financial Officer at ProBioGen (and the subsidiary MiGenTra)
ProBioGen was founded in Berlin in 1994, and has been part of the Egyptian Minapharm Group since 2010. The biotech company and its subsidiary MiGenTra operate around the globe and have years of experience developing and producing biopharmaceuticals…
1 Min
More Show more items
